Article
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo.
Leukemia - 1 Apr 2022
Spohr Corinna, Poggio Teresa, Andrieux Geoffroy, Schönberger Katharina, Cabezas-Wallscheid Nina, Boerries Melanie, Halbach Sebastian, Illert Anna L, Brummer Tilman
Abstract excerpt
Internal tandem duplications (ITD) of the FMS-like tyrosine kinase 3 (FLT3) predict poor prognosis in acute myeloid leukemia (AML) and often co-exist with inactivating DNMT3A mutations. In vitro studies implicated Grb2-associated binder 2 (GAB2) as FLT3-ITD effector. Utilizing a Flt3-ITD knock-in, Dnmt3a haploinsufficient mouse model, we demonstrate that Gab2 is essential for the development of Flt3-ITD driven...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
